Novo Nordisk’s New Obesity Pill Beats Wegovy In Early Trial
Forbes Healthcare
SEPTEMBER 11, 2024
Data from an early stage clinical trial suggests Novo Nordisk’s new weight loss pill amycretin could produce greater and more rapid weight loss than its popular obesity injection Wegovy.
Let's personalize your content